Nulibry Evrópusambandið - íslenska - EMA (European Medicines Agency)

nulibry

tmc pharma (eu) limited - fosdenopterin hydrobromide dihydrate - metal metabolism, inborn errors - Önnur meltingarvegi og efnaskipti vörur, - nulibry is indicated for the treatment of patients with molybdenum cofactor deficiency (mocd) type a.

Elvanse Adult Hart hylki 30 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

elvanse adult hart hylki 30 mg

takeda pharmaceuticals international ag ireland branch - lisdexamfetaminum dimesylate - hart hylki - 30 mg

Elvanse Adult Hart hylki 50 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

elvanse adult hart hylki 50 mg

takeda pharmaceuticals international ag ireland branch - lisdexamfetaminum dimesylate - hart hylki - 50 mg

Elvanse Adult Hart hylki 70 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

elvanse adult hart hylki 70 mg

takeda pharmaceuticals international ag ireland branch - lisdexamfetaminum dimesylate - hart hylki - 70 mg

Volidax Hart hylki 30 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

volidax hart hylki 30 mg

teva b.v.* - lisdexamfetaminum dimesylate - hart hylki - 30 mg

Volidax Hart hylki 50 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

volidax hart hylki 50 mg

teva b.v.* - lisdexamfetaminum dimesylate - hart hylki - 50 mg

Volidax Hart hylki 70 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

volidax hart hylki 70 mg

teva b.v.* - lisdexamfetaminum dimesylate - hart hylki - 70 mg

Elvanse Adult Hart hylki 20 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

elvanse adult hart hylki 20 mg

takeda pharmaceuticals international ag ireland branch - lisdexamfetaminum dimesylate - hart hylki - 20 mg